A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures

NCT04257604 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 243

Last updated 2020-02-06

No results posted yet for this study

Summary

The primary objective of the present study will be to assess the effectiveness of add-on perampanel in participants with focal seizures in a real-life clinical setting.

Conditions

  • Partial Seizures

Interventions

DRUG

Perampanel

Perampanel tablets.

Sponsors & Collaborators

  • Eisai Limited

    lead INDUSTRY

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-03
Primary Completion
2019-04-30
Completion
2019-04-30
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04257604 on ClinicalTrials.gov